Dear Editor,

COVID-19 has become an important public health problem internationally in 2020. The disease caused problems in several countries around the world. The infection can result in febrile illness with a respiratory problem.\[[@ref1]\] In our previous report, we have shown the limitation on the basic screening tool, temperature monitoring, for mass screening for people coming from risk areas.\[[@ref2]\] In clinical practice in preventive medicine, adding to the screening for risk population, the early diagnosis on suspicious cases of COVID-19 is similarly important. In general, common investigative tools include CT lung imaging and Reverse transcription polymerase chain reaction (RT-PCR).\[[@ref3]\] Fang *et al*. reported that the detections rates for initial chest CT and RT-PCR for COVID-19 detection among the clinically suspicious cases were equal to 98% and 71%, respectively.\[[@ref3]\] Nevertheless, there is still no study on cost and utility of tools for diagnosis.

Here, the authors performed a medical economics analysis to clarify the cost--utility of CT versus RT-PCR for COVID-19 detection. The primary data on cost are hereby referred to referencing costs for chest CT and RT-PCR by the Thai Ministry of Public Health and presented in USD. For utility, the data in the referencing publication by Fang *et al*. are directly referred.\[[@ref3]\] The number of participants in the referencing data source is equal to 51. The cost--utility analysis is done according to the standard medical economics technique. The cost--utility value is directly calculated as "cost--utility = cost/utility." According to the study, cost, utility, and cost per utility of chest CT versus RT-PCR for COVID-19 detection are presented in [Table 1](#T1){ref-type="table"}. Based on the analysis, the cost per utility for chest CT is higher. This might imply that RT-PCR tool is still a good choice for early detection of COVID-19 in clinically suspicious cases, especially for the developing countries with limited resource.

###### 

Cost, utility, and cost per utility of for chest CT versus RT-PCR for COVID-19 detection

                         Chest CT   RTPCRt
  ---------------------- ---------- --------
  Cost (USD)             94.67      50.49
  Utility (%)            98%        71%
  Cost-utility (USD)\*   96.60      71.53

\*Cost-utility is equal to cost per utility (cost/utility)
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